Restora Medical, Inc.
Amendment
CIK: 0002008412·Biotechnology·DELAWARE·Filed: Jun 18, 2026
Total Offering
$12,049,999
Amount Sold
$6,024,999
Investors
11
First Sale
Feb 19, 2025
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2023
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Quan Ni | |
| Chau Khuong | |
| Tianji Zhu | |
| Ye Zhang | |
| Lixiao Wang |
Company
SEC Filing
0002008412-26-000007
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free